Our mobile applications extend the reach of digital health interventions, providing on-the-go access to patient engagement tools, adherence tracking, and remote monitoring. Designed for both iOS and Android, our apps offer seamless integration with wearables, smart assistants, and healthcare platforms, ensuring a user-friendly experience while maintaining security and compliance.
This study describes the protocol for a feasibility trial evaluating App4Independence (A4i), a digital health platform designed to improve illness self-management and treatment engagement among individuals
This study examined whether machine learning could predict individual responses to and engagement with a smartphone-based digital intervention among people with schizophrenia and related psychotic disorders. Researchers
The study examined the feasibility of A4i, a multi-feature mobile health application designed to support illness self-management among people with schizophrenia spectrum and other psychotic
The study was a single-blinded randomized trial. This trial was undertaken to generate feasibility data that might inform the design and utility of future effectiveness
Effective clinical services and treatments for schizophrenia spectrum populations are commonly hindered by illness complexity. Considering this, digital health holds promise in the effort to
A4i (App4Indpendence) is a platform for supporting people with complex behavioural and mental health conditions. Currently, A4i is being used to support the recovery processes in psychosis and schizophrenia, and newly in opioid use disorders.
